THC behaves very differently from most recreational substances. Alcohol clears in hours. Most pharmaceuticals clear in a day or two. THC can show up on a drug test a month after the last use. The reason comes down to a single chemical property — and what your body does with it.
Lipophilic: what it actually means
THC is highly lipophilic, which literally translates to "fat-loving." In practical terms, it means THC dissolves easily in fats and oils, and dissolves poorly in water.
This is the opposite of how most water-soluble substances behave. Alcohol dissolves easily in your bloodstream (which is mostly water), distributes evenly throughout the body's water content, and clears predictably as your liver processes it. Lipophilic compounds don't follow that pattern. They partition into fatty tissues, where they accumulate and release slowly over time.
The lipophilicity of cannabinoids is measured by a value called the octanol-water partition coefficient (LogP). For reference: ethanol has a LogP of around -0.31, meaning it slightly prefers water. THC has a LogP of approximately 6.97, meaning it prefers fat by a factor of about a million. CBD is similar. Most cannabinoids are in the same range.
That single chemical property — extreme preference for fat over water — explains nearly everything unusual about how cannabis behaves in the body.
The distribution phase
When THC enters your bloodstream (whether from inhalation or eventually from oral consumption), it doesn't stay there long. The plasma is a watery environment, and THC has somewhere it would rather be.
Within minutes to hours, THC moves out of the bloodstream and into tissues with high fat content:
- Brain. Approximately 60% lipid content. THC reaches the brain quickly because of its lipophilicity (which is also part of why it crosses the blood-brain barrier so easily) and produces its effects there.
- Liver. Rich in lipids and metabolically active. The liver also processes THC for elimination, complicating the picture.
- Adipose tissue. The body's main fat stores. This is where the long-term deposit happens.
- Other fatty tissues. Bone marrow, certain organ fat deposits, lipid-rich nervous tissue.
The redistribution from blood to fat is the reason blood THC levels drop relatively quickly after the initial peak. But the total body burden doesn't drop with it. The THC has just moved from a water-rich compartment (blood) to a lipid-rich compartment (fat). It's still in you.
What "stored in fat" actually means
The word "stored" can be misleading. THC isn't sitting inertly in fat tissue, waiting to be released. It's in a dynamic equilibrium with the surrounding water-based tissues.
At any moment, some THC is moving from fat back into circulation, and some is moving from circulation back into fat. When the blood concentration is high (immediately after consumption), the net flow is into fat. When the blood concentration drops, the net flow reverses — fat releases stored THC back into circulation, where it can either produce effects, be metabolized by the liver, or get redeposited elsewhere.
This equilibrium is why heavy chronic users sometimes report low-level cannabis effects days after their last use, particularly during exercise. Exercise mobilizes fat tissue for energy, releasing some of the deposited THC along with the fatty acids. The release isn't usually enough to produce a noticeable high, but it's enough to keep the cannabinoid pipeline flowing.
The chronic accumulation problem
For occasional users, the fat-storage dynamic doesn't matter much. A single use deposits a small amount of THC in fat tissue, and it clears out over days. By a week later, it's mostly gone.
For chronic users, the deposit accumulates. Each daily use adds new THC to fat stores faster than the previous deposits can clear. Over weeks and months, the total body burden of cannabinoids in fat tissue grows substantially.
The biology is simple. The half-life of THC and its metabolites in fat tissue is much longer than the dosing interval for most chronic users. If a compound has an effective fat-tissue half-life of 7 days and you're dosing every 24 hours, you're depositing faster than you're clearing. The body load grows toward an equilibrium that depends on the dosing rate.
This is the mechanism behind extended detection windows. Heavy daily users routinely test positive on urine screens 30+ days after stopping use, sometimes much longer. The peer-reviewed literature includes documented cases extending to 67 days. The fat stores are slowly releasing stored cannabinoids the whole time, providing a continuous supply for liver metabolism and renal excretion.
Why this is unusual for a drug
Most recreational and pharmaceutical drugs don't behave this way. Alcohol, opioids, stimulants, and most prescription medications are designed to (or naturally) clear from the body on a timescale measured in hours. The pharmacokinetic models for these substances assume relatively rapid distribution and elimination.
THC breaks those models. The pharmacokinetics involve at least three compartments — blood, lean tissue, and fat tissue — with very different time constants for each. Drug developers working on cannabinoid medications have to design around this. Clinical trials of CBD products often involve weeks of steady-state dosing because the body takes that long to reach equilibrium.
From a regulatory perspective, this is why drug testing for cannabis is so unlike testing for other substances. An employer testing for alcohol has a roughly 12-hour window of detection. An employer testing for cannabis has a window that ranges from days to months depending on the test type and the subject's usage history. The fat-storage mechanism makes "did this person use recently?" a much harder question to answer.
What this means in practice
Body composition matters
People with more body fat have more storage capacity for cannabinoids. All else equal, a person with 25% body fat will deposit more THC than a person with 12% body fat from the same dose, and will take longer to clear it. This is one of the largest individual factors in cannabinoid pharmacokinetics, ahead of sex, age, or even metabolic rate.
Weight loss can re-release THC
Active fat loss — whether from diet, exercise, illness, or other causes — mobilizes adipose tissue. When fat cells release stored fatty acids for energy, they also release any lipophilic compounds deposited in them. For a recent chronic user trying to clear THC before a drug test, exercise can paradoxically raise blood and urine cannabinoid levels in the short term.
The implication: don't dramatically change your diet or exercise pattern in the days immediately before a drug test. Counterintuitive but real.
Detox products mostly don't work
The marketing claims around "THC detox" products typically rely on a misunderstanding of where THC is and how it's eliminated. Diuretics dilute urine, which most modern tests detect via specific gravity checks. Sweat-based "flushes" remove an insignificant fraction of the body load. Supplements claiming to "bind to" THC have no mechanism to extract it from fat stores.
The only reliable way to clear THC is time. The body releases it from fat stores at its own pace and metabolizes it through normal liver and kidney function. No commercially available product has been shown to meaningfully accelerate that process for chronic users.
The CYP enzyme interaction
One thing worth knowing if you take prescription medications: the CYP enzymes that metabolize THC also handle many pharmaceuticals. Chronic high-dose cannabinoid use can affect the metabolism of medications processed by the same enzyme pathways, potentially altering their efficacy or side effects. This is more relevant for CBD (which is a stronger CYP inhibitor) than for THC, but worth discussing with a physician if you're on important medications.
The pharmacology behind the policy
The fat-storage mechanism has policy implications most consumers don't think about. Workplace drug testing policies, DUI standards, child custody hearings, and probation requirements all rely on the assumption that detection of THC metabolites indicates recent impairment. That assumption is roughly accurate for occasional users but breaks down for heavy chronic users, where positive tests can occur weeks after last use without any plausible recent impairment.
Some jurisdictions have started recognizing this — moving from "any detectable THC" standards toward more nuanced measures that account for chronic use patterns. But the science has run ahead of policy in this area, and the lipophilic nature of cannabinoids continues to create real-world situations where the test results don't match the impairment reality.
The biology isn't going to change. THC is going to remain a fat-loving molecule that accumulates in adipose tissue with chronic use and releases slowly over time. The policy questions about what to do with that biological reality are still being worked out.
